Findings show current chronic pain tied to worse functional outcomes versus past or no pain. -- More on chronic pain

Researchers say that 'the brain does not treat traumatic memories as regular memories, or perhaps even as memories at all.'

New research published in Translational Psychiatry sheds light on how ketamine, a drug known for its rapid antidepressant effects, specifically alters brain activity in people with treatment-resistant depression.

When Annie Liontas was 35, they got into a bike accident while riding without a helmet. An author and writing professor at George Washington University, Liontas continues to live with the repercussions of the three brain injuries.

What if you could successfully treat PTSD in two weeks instead of 12? Please note: This podcast is designed for mental health practitioners and providers.

Researchers made a significant breakthrough in understanding the genetic basis of anxiety disorders (ADs), which affect over 280 million people globally.

Stroke is an abrupt, devastating disease that instantly changes a person's life and has the potential to cause lasting disability or death. However, the condition also has profound effects on the patient's loved ones who are often called to make difficult decisions quickly.

The military will conduct research and clinical trials to determine whether psychedelic drugs, such as these psilocybin capsules, can treat service members suffering from post-traumatic stress disorder and traumatic brain injury under provisions of the defense spending bill approved by Congress last week.

As we head into the winter holidays, John Yang speaks with epidemiologist Katelyn Jetelina about how to stay healthy this season.

The Food and Drug Administration (FDA) says it will consider approval of psychedelic drug MDMA to be used in therapy for post-traumatic stress disorder (PTSD). -- More on psychedelic treatment